Free Trial

N4 Pharma (N4P) Competitors

N4 Pharma logo
GBX 0.35 -0.03 (-6.67%)
As of 07/3/2025 11:03 AM Eastern

N4P vs. HELD, HLN, BXP, HIK, HCM, INDV, AMYT, AGY, APH, and ANCR

Should you be buying N4 Pharma stock or one of its competitors? The main competitors of N4 Pharma include Hellenic Dynamics (HELD), Haleon (HLN), Beximco Pharmaceuticals (BXP), Hikma Pharmaceuticals (HIK), HUTCHMED (HCM), Indivior (INDV), Amryt Pharma (AMYT), Allergy Therapeutics (AGY), Alliance Pharma (APH), and Animalcare Group (ANCR). These companies are all part of the "drug manufacturers - specialty & generic" industry.

N4 Pharma vs. Its Competitors

N4 Pharma (LON:N4P) and Hellenic Dynamics (LON:HELD) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations and earnings.

In the previous week, N4 Pharma's average media sentiment score of 0.00 equaled Hellenic Dynamics'average media sentiment score.

Company Overall Sentiment
N4 Pharma Neutral
Hellenic Dynamics Neutral

N4 Pharma has higher revenue and earnings than Hellenic Dynamics. N4 Pharma is trading at a lower price-to-earnings ratio than Hellenic Dynamics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
N4 Pharma£8.84K170.49-£1.63M-£0.35-1.01
Hellenic DynamicsN/AN/A-£5.22M-£3.550.00

Hellenic Dynamics has a net margin of 0.00% compared to N4 Pharma's net margin of -18,399.86%. N4 Pharma's return on equity of -90.68% beat Hellenic Dynamics' return on equity.

Company Net Margins Return on Equity Return on Assets
N4 Pharma-18,399.86% -90.68% -56.00%
Hellenic Dynamics N/A -364.21%N/A

0.1% of Hellenic Dynamics shares are owned by institutional investors. 18.0% of N4 Pharma shares are owned by company insiders. Comparatively, 72.9% of Hellenic Dynamics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Hellenic Dynamics beats N4 Pharma on 5 of the 9 factors compared between the two stocks.

Get N4 Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for N4P and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding N4P and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

N4P vs. The Competition

MetricN4 PharmaDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£1.51M£2.11B£5.50B£2.97B
Dividend Yield3.12%2.92%5.38%5.02%
P/E Ratio-1.014.1427.55146.59
Price / Sales170.49545.47389.87240,167.56
Price / Cash2.2510.3536.6327.97
Price / Book0.7811.898.075.32
Net Income-£1.63M£21.15B£3.17B£5.90B
7 Day Performance-11.39%2.17%2.83%0.92%
1 Month Performance-30.00%4.88%3.70%5.20%
1 Year Performance-22.22%2.85%35.41%80.77%

N4 Pharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
N4P
N4 Pharma
N/AGBX 0.35
-6.7%
N/A-21.2%£1.51M£8.84K-1.015Gap Up
HELD
Hellenic Dynamics
N/AGBX 0.01
flat
N/AN/A£14KN/A0.00N/A
HLN
Haleon
1.3884 of 5 stars
GBX 379.40
+0.5%
GBX 457
+20.5%
+14.4%£34.24B£11.07B31.9125,408Insider Trade
BXP
Beximco Pharmaceuticals
N/AGBX 35.12
-5.1%
N/A-11.0%£23.94B£7.08T3.775,500
HIK
Hikma Pharmaceuticals
3.9731 of 5 stars
GBX 2,014.70
+0.8%
GBX 2,560
+27.1%
+9.0%£5.59B£3.74B19.779,100
HCM
HUTCHMED
N/AGBX 219
-0.9%
N/A-16.1%£2.38B£771.01M-55.901,760
INDV
Indivior
3.1462 of 5 stars
GBX 986
-2.2%
GBX 1,650
+67.3%
-2.8%£1.54B£1.40B-817.541,000
AMYT
Amryt Pharma
N/AN/AN/AN/A£457.11M£210.24M-4.33290Gap Down
AGY
Allergy Therapeutics
N/AGBX 7.30
flat
N/A+66.0%£358.80M£72.18M-7.04612High Trading Volume
APH
Alliance Pharma
2.1829 of 5 stars
GBX 64.70
flat
GBX 6,250
+9,560.0%
N/A£350.32M£183.50M-10.4391,000
ANCR
Animalcare Group
N/AGBX 295.75
+1.3%
N/A+25.6%£202.77M£84.90M5.51220High Trading Volume

Related Companies and Tools


This page (LON:N4P) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners